Literature DB >> 11994401

Stat proteins and oncogenesis.

Jacqueline Bromberg1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11994401      PMCID： PMC150969          DOI： 10.1172/JCI15617

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  44 in total

Review 1.  Modulation of STAT signaling by STAT-interacting proteins.

Authors:  K Shuai
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

2.  STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma.

Authors:  C K Lee; E Smith; R Gimeno; R Gertner; D E Levy
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

3.  Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts.

Authors:  D Deon; S Ahmed; K Tai; N Scaletta; C Herrero; I H Lee; A Krause; L B Ivashkiv
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

4.  Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.

Authors:  J F Bromberg; C M Horvath; Z Wen; R D Schreiber; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

Review 5.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 6.  STATs in oncogenesis.

Authors:  T Bowman; R Garcia; J Turkson; R Jove
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 7.  Roles of STAT3 defined by tissue-specific gene targeting.

Authors:  S Akira
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

8.  Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes.

Authors:  T Ouchi; S W Lee; M Ouchi; S A Aaronson; C M Horvath
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

9.  Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.

Authors:  V Sexl; R Piekorz; R Moriggl; J Rohrer; M P Brown; K D Bunting; K Rothammer; M F Roussel; J N Ihle
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

Review 10.  The role of STATs in transcriptional control and their impact on cellular function.

Authors:  J Bromberg; J E Darnell
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867
View more
  318 in total

Review 1.  What does Stat3 do?

Authors:  David E Levy; Chien-kuo Lee
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Series introduction. JAK-STAT signaling in human disease.

Authors:  Christian W Schindler
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

Review 4.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

5.  Structure-function correlation of G6, a novel small molecule inhibitor of Jak2: indispensability of the stilbenoid core.

Authors:  Anurima Majumder; Lakshmanan Govindasamy; Andrew Magis; Róbert Kiss; Tímea Polgár; Rebekah Baskin; Robert W Allan; Mavis Agbandje-McKenna; Gary W Reuther; György M Keseru; Kirpal S Bisht; Peter P Sayeski
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 6.  Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

Authors:  Amani Batarseh; Vassilios Papadopoulos
Journal:  Mol Cell Endocrinol       Date:  2010-06-30       Impact factor: 4.102

7.  Quantitative specificity of STAT1 and several variants.

Authors:  Basab Roy; Zheng Zuo; Gary D Stormo
Journal:  Nucleic Acids Res       Date:  2017-08-21       Impact factor: 16.971

8.  Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitors.

Authors:  Matthew B Minus; Haopei Wang; Jaime O Munoz; Alexandra M Stevens; Alicia E Mangubat-Medina; Michael J Krueger; Wei Liu; Moses M Kasembeli; Julian C Cooper; Mikhail I Kolosov; David J Tweardy; Michele S Redell; Zachary T Ball
Journal:  Org Biomol Chem       Date:  2020-05-06       Impact factor: 3.876

9.  XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.

Authors:  Yan Cheng; Michael P Holloway; Kevin Nguyen; Dilara McCauley; Yosef Landesman; Michael G Kauffman; Sharon Shacham; Rachel A Altura
Journal:  Mol Cancer Ther       Date:  2014-01-15       Impact factor: 6.261

Review 10.  Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.

Authors:  Ricardo D Coletta; Paul Jedlicka; Arthur Gutierrez-Hartmann; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.